Medical treatment of craniosynostosis: Recombinant noggin inhibits coronal suture closure in the rat craniosynostosis model

Orthodontics and Craniofacial Research

Volumn 12, Issue 3, 2009, Pages 254-262

  Shen, K ^a   Krakora, S M ^a   Cunningham, M ^b   Singh, M ^a   Wang, X ^a   Hu, F Z ^a,c   Post, J C ^a,c   Ehrlich, G D ^a,c  

^a ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Craniosynostosis; FGFR2; Noggin; Tissue engineering; Xenotransplant

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CARRIER PROTEIN; FGFR2 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; NOGGIN PROTEIN; RECOMBINANT PROTEIN;

ACROCEPHALOSYNDACTYLY; ANIMAL; ARTICLE; CELL LINE; CELL LINEAGE; CHIMERA; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; CYSTINE KNOT MOTIF; DISEASE MODEL; DRUG ANTAGONISM; DURA MATER; FRONTAL BONE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MUTATION; NUDE RAT; OSTEOBLAST; PATHOLOGY; RAT; SKULL; TRANSPLANTATION; XENOGRAFT;

ACROCEPHALOSYNDACTYLIA; ANIMALS; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CELL LINE; CELL LINEAGE; CHIMERA; CRANIAL SUTURES; CRANIOFACIAL DYSOSTOSIS; CRANIOSYNOSTOSES; CYSTINE KNOT MOTIFS; DISEASE MODELS, ANIMAL; DURA MATER; FRONTAL BONE; HUMANS; MUTATION; OSTEOBLASTS; PARIETAL BONE; RATS; RATS, NUDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECOMBINANT PROTEINS; SKULL; TRANSPLANTATION, HETEROLOGOUS;

EID: 70350344035     PISSN: 16016335     EISSN: 16016343     Source Type: Journal    
DOI: 10.1111/j.1601-6343.2009.01460.x     Document Type: Article

References (22)

1. French LR, Jackson IT, Melton LJ. A population-based study of craniosynostosis. J Clin Epidemiol 1990;43:69-73.
2. Thompson DN, Malcolm GP, Jones BM, Harkness WJ, Hayward RD. Intracranial pressure in single-suture craniosynostosis. Pediatr Neurosurg 1995;22:235-40.
3. Cohen MM Jr. Sutural biology and the correlates of craniosynostosis. Am J Med Genet 1993;47:581-616.
4. Crouzon O. Dysostose cranio-faciale hereditaire. Bull Mem Soc Hop Paris 1912;33:545-55.
5. Cohen MM, Kreiborg S. Birth prevalence studies of the Crouzon syndrome: comparison of direct and indirect methods. Clin Genet 1992;41:12-5.
6. Gorlin RJ, Cohen MM. Syndromes of the Head and Neck, 3rd edn. New York: McGraw-Hill Inc.; 1990. pp. 460-1.
7. Preston RA, Post JC, Keats BJB, Aston CE, Ferrell RE, Priest J et al. A gene for Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 1995;4:1387-90.
8. Gorry MC, Preston RA, White GJ, Zhang Y, Sinhal VK, Losken HW et al. Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 1995;4:1387-90.
9. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994;8:98-103. (Pubitemid 24274068)
10. Oldridge M, Lunt PW, Zackai EH, McDonald-McGinn DM, Muenke M, Moloney DM. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. Hum Mol Genet 1997;6:137-43.
11. Hollway GE, Suthers GK, Haan EA, Thompson E, David DJ, Gecz J et al. Mutation detection in FGFR2 craniosynostosis syndromes. Hum Genet 1997;99:251-5.
12. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994;8:269-74.
13. Golla A, Lichmer P, von Gernet S, Winterpacht A, Fairley J, Murken J. Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family. J Med Genet 1997;34:683-4.
14. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997;1:36-41.
15. Bresnick S, Schendel S. Crouzon's disease correlates with low fibroblastic growth factor receptor activity in stenosed cranial sutures. J Craniofac Surg 1995;6:245-8.
16. Brunet LJ, McMahon JA, McMahon AP, Harland RM. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 1998;280:1455-7.
17. McMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM, McMahon AP. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 1998;12:1438-52.
18. Warren SM, Greenwald JA, Spector JA, Bouletreau P, Mehrara BJ, Longaker MT. New developments in cranial suture research. Plast Reconstr Surg 2001;107:523-40.
19. Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Fagenholz PJ, Smith LE. In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol 2001;158:441-52.
20. Mansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factors and fibroblast growth factor receptor 2 activating mutations block mineralization and induces apoptosis in osteoblasts. J Cell Biol 2000;149:1297-308.
21. Aubin JE, Liu F, Malaval L, Gupta AK. Osteoblast and chondroblast differentiation. Bone1995;17(Suppl):77S-83S.
22. Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT. The BMP antagonist Noggin regulates cranial suture fusion. Nature 2003;422:625-9.